CKM and mesothelioma: It is easy to speculate that the immunologic TME is more favorable for elicitation of antitumor immunity in an immunogenic tumor (such as AB12 mesothelioma), and thus CKM treatment would become functionally redundant and thus play marginal effect in further improving the oncolytic therapeutic efficacy.